Daewoong Pharmaceutical announced on the 25th that it has signed a contract for the export of the botulinum toxin "Nabota" to Kuwait. This contract marks the fifth entry into the Middle East, and it is the fourth entry among the six Gulf Coast countries following the United Arab Emirates (UAE), Saudi Arabia, and Qatar. The company noted, "Our goal is to launch the product in Kuwait in the first half of next year," adding, "Daewoong Pharmaceutical currently has the largest presence in Middle Eastern countries among domestic botulinum toxin brands."
CKD BiO announced on the 25th that its operating profit for the second quarter of this year was 2.9 billion won, a decline of 42.3% compared to the same period last year. The sales revenue for the second quarter decreased by 19.1% to 41.2 billion won, and the net loss for the period was 500 million won. Cumulative sales revenue for the first half of this year totaled 83.7 billion won, with operating profit at 5 billion won and net income at 400 million won.
Yuhan Corporation announced on the 25th that it has signed a business agreement with SIS Dental, the longest-standing dental corporation in South Korea, to promote joint projects for implants. According to the agreement, the two companies plan to launch the 'Yuhan EverTIS' implant. The existing EverTIS implant produced by SIS Dental is a product that has improved quality stability by increasing the automation rate of the production process. The company stated it plans to establish a comprehensive cooperation system that includes joint planning, marketing, and sales of all dental medical devices and pharmaceuticals with SIS Dental.
Cynosure Lutronic, a global leader in energy-based devices, announced on the 25th that it has participated in a donation drive led by Hahn & Company to help victims affected by the recent heavy rains across the country. Hahn & Company's entire portfolio (Cynosure Lutronic, Namyang Dairy Products, Korean Air, Daehan C&D Service, Lahan Hotel, Solmix, Ssangyong C&E Ichiline Shipping, Enpulse, K Car, Coavis, SK Micro Works, SK Specialty, and SK Shipping) participated, contributing a total of 2 billion won to the Hope Bridge National Disaster Relief Association.
The Sun Village in Hongcheon, Gangwon Province, will host a healing program called "Holistic Healing Tai Chi Retreat," which combines traditional Chinese martial arts and meditation, on the 27th. Participation is free, and anyone staying at the Sun Village can join on a first-come, first-served basis. Tai Chi is known as "moving meditation" that balances the body and mind through slowly flowing movements and breathing, with more than 300 million practitioners worldwide.
Dong-A Pharmaceutical has launched the Spanish olive oil "Olivia Picual." To celebrate the new product's launch, the company announced that it will offer the maximum benefit price as part of a promotion on its Naver brand store until Aug. 10. It will also give away "Vitagran Lemon Juice," which pairs well with the olive oil. This product has an acidity of 0.1-0.2%, which is low even among extra virgin grades that are managed below 0.8%. The lower the acidity, the faster and more hygienically fresh olives are processed. The product will also be featured on various channels, including Dong-A Pharmaceutical's official mall "D Mall" and Coupang.
Dongkook Pharmaceutical announced that it has newly entered major convenience stores such as GS25 and CU, following its product 'Egis Smart Gummy Chew,' an alcohol hangover remedy. This product can be easily chewed without water, with 1-3 pieces taken before or after drinking. It contains 'Iceplant Complex Concentrate' as a raw material that meets the Ministry of Food and Drug Safety's hangover relief clinical application test guidelines. The company conducted human application tests on this raw material with 80 adults and found a rapid and clear hangover improvement effect, with blood alcohol concentration decreased by 15.1% and acetaldehyde concentration decreased by 21.4% after 30 minutes of ingestion.
Prestige Biopharma's R&D Center, Prestige Biopharma IDC, recently announced on the 25th that it has filed a domestic patent for "a pharmaceutical composition for cancer combination therapy based on anti-CTHRC1 monoclonal antibody PBP1710." This patent contains a new combination therapy strategy intended to complement the limitations of existing chemotherapy and enhance the response rate in solid tumor treatments. The key is to improve therapeutic efficiency by regulating the excessive accumulation of the extracellular matrix (ECM), which is a major cause of hindering drug delivery in solid tumors. The company expects potential for global technology transfer and entry into the combination therapy kit and companion diagnostics market.
D&D Pharmatech announced on the 25th that it has completed the 24th week of administration for its clinical phase II trial of the metabolism-related steatosis (MASH) treatment 'DD01' currently under clinical development in the United States. The company is analyzing major blood biomarkers, including changes in weight. DD01 is a long-acting dual agent targeting both GLP-1 and glucagon receptors that D&D Pharmatech has developed.
HK inno.N announced that its YouTube channel "Channel inno.N (CH. inno.N)" has received the YouTube Award for the pharmaceutical field at the 2025 Social i-AWARD. This is the largest social media award ceremony in Korea organized by the Korea Internet Professional Association under the Ministry of Science and ICT. The channel inno.N has approximately 27,000 subscribers.
Cha University announced on the 25th that it has signed a business agreement with Pocheon City and Cha Meditech to revitalize the bio-food industry ecosystem in the Pocheon region. Through this agreement, the three institutions promised to promote the Pocheon area as a hub for bio-food convergence industries through regional cooperation, talent development, and strengthening industry-academia-research collaboration.